Creative Medical Technology Holdings (CELZ) EBITDA Margin Growth (5y) (2022 - 2025)
Powered by 
Analysis
Creative Medical Technology Holdings (CELZ) EBITDA Margin Growth (5y) (2022 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.22 Bn | 9.37 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.02 Bn | 5.02 Bn | - |
| 3 | Iovance Biotherapeutics | 3.66 Bn | 3.36 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn |
| 5 | uniQure | 3.00 Bn | 3.00 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.53 Bn | 2.53 Bn | - |
| 7 | Precigen | 2.37 Bn | 2.37 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.17 Bn | 1.37 Bn | 251.87 Mn |
| 9 | Vericel | 1.95 Bn | 1.79 Bn | 56.40 Mn |
| 10 | Creative Medical Technology Holdings | 1.42 Mn | 1.42 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -6.30 Mn |
| Mar 31, 2025 | -5.46 Mn |
| Dec 31, 2024 | -7.04 Mn |
| Jun 30, 2024 | -1.99 Mn |
| Dec 31, 2023 | -5.85 Mn |
| Sep 30, 2023 | -2.52 Mn |
| Dec 31, 2022 | -2.86 Mn |